VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $237,782,000 | -45.8% | 1,333,014 | -32.6% | 0.37% | -42.9% |
| Q2 2015 | $439,036,000 | -7.5% | 1,976,306 | -17.3% | 0.66% | -7.4% |
| Q1 2015 | $474,455,000 | +42.5% | 2,388,757 | +2.7% | 0.71% | +36.8% |
| Q4 2014 | $332,937,000 | +12.2% | 2,326,449 | +2.9% | 0.52% | +2.8% |
| Q3 2014 | $296,733,000 | +7.0% | 2,261,683 | +2.8% | 0.50% | +7.9% |
| Q2 2014 | $277,395,000 | +7.6% | 2,199,452 | +12.5% | 0.47% | +1.3% |
| Q1 2014 | $257,767,000 | +14.0% | 1,955,301 | +1.5% | 0.46% | +9.0% |
| Q4 2013 | $226,176,000 | +14.9% | 1,926,544 | +2.1% | 0.42% | +3.7% |
| Q3 2013 | $196,882,000 | +31.1% | 1,887,105 | +8.1% | 0.41% | +22.2% |
| Q2 2013 | $150,214,000 | – | 1,745,053 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |